SOURCE: Healtheuniverse Inc.

March 22, 2007 13:49 ET

Healtheuniverse Focuses Research on Reconstructive Surgery Using Non-Embryonic Stem Cells for Bone, Facial and Breast Implants

COVINA, CA -- (MARKET WIRE) -- March 22, 2007 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today that research protocols are being prepared to treat women who have undergone mastectomies and patients that been disfigured by other surgeries or injuries requiring bone and facial implants. Tissue engineered from the Company's patented adult stem cell process offers clinical advantages in that the implants retain their shape and structure and also eliminate a separate surgery to extract healthy tissue. The Company intends to commercialize its proprietary technology through packaged products and licensing agreements, once human clinical trials are completed.

Reconstructive surgery to replace tissues lost to cancer or other disease could benefit from stem-cell generated natural implants that do not shrink or lose their shape. Studies have shown that conventional soft tissue implants can lose 40 percent to 60 percent of their volume over time. Examples are breast tissue reconstruction after breast cancer surgery and facial soft tissue reconstruction following cancer or trauma surgeries.

Natural implants often require separate surgical procedures from a healthy location of the patient's body to obtain tissue for constructing the implant. Healtheuniverse's adult stem cell procedures do not require extensive surgery because cells needed for the implant are obtained in a less invasive needle procedure.

About HEALTHeUNIVERSE Inc.

HEALTHeUNIVERSE Inc. is engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in disease related commercial applications. More information on Healtheuniverse is available online at http://healtheuniverse.com/

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    800-719-7424
    Email Contact